PepGen Inc. (PEPG) income statement
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.83−0.05 (-1.29%)
Close on Nov 18, 2026Market cap $265.26MP/E –Yield –
PepGen Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -67.4%
Financial strength
- Current ratio
- 13.36
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 252.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.22
- Dividend yield
- –
See a number that looks wrong?